Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma - a study by the EORTC Soft Tissue and Bone Sarcoma Group

By Judson I.   Radford J.A.   Harris M.   Blay J.-Y.   van Hoesel Q.   le Cesne A.   van Oosterom A.T.   Clemons M.J.   Kamby C.   Hermans C.   Whittaker J.   Donato di Paola E.   Verweij J.   Nielsen S.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 870-877

Elsevier

Access to resources Recommend Favorite

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial - an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group Study

By Pectasides D.   Visvikis A.   Aspropotamitis A.   Halikia A.   Karvounis N.   Dimitriadis M.   Athanassiou A.  

European Journal of Cancer, Vol. 36, Iss. 1, 2000-01 ,pp. : 74-79

Elsevier

Access to resources Recommend Favorite

Phase II clinical trial with pegylated liposomal doxorubicin

By Poveda A.  

Sarcoma, Vol. 9, Iss. 3-4, 2005-09 ,pp. : 127-132

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer

By Ulrich-Pur Herbert   Kornek Gabriela   Haider Karin   Kwasny Werner   Payrits Thomas   Dworan Nina   Vormittag Laurenz   Depisch Dieter   Lang Fritz   Scheithauer Werner  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of DaunoXome ( R) in advanced urothelial transitional cell carcinoma

By Fossa S.D.   Aass N.   Paro G.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1131-1132

Elsevier

Access to resources Recommend Favorite